J.W. Cole Advisors, Inc. Hcw Biologics Inc. Transaction History
J.W. Cole Advisors, Inc.
- $3.14 Billion
- Q1 2025
A detailed history of J.W. Cole Advisors, Inc. transactions in Hcw Biologics Inc. stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 53,402 shares of HCWB stock, worth $226,958. This represents 0.02% of its overall portfolio holdings.
Number of Shares
53,402Holding current value
$226,958% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding HCWB
# of Institutions
15Shares Held
1.14MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.19 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA243KShares$1.03 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.01 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$560,9570.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$319,2430.01% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $152M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...